Laurent Garderet

Summary

Country: France

Publications

  1. doi request reprint Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomi
    Laurent Garderet
    University Hospital Saint Antoine, Paris, France
    J Clin Oncol 30:2475-82. 2012
  2. doi request reprint [Treatment of myeloma in the elderly]
    Laurent Garderet
    Hopital Saint Antoine, Service d Hématologie et de Thérapie Cellulaire, 184, rue du Faubourg Saint Antoine, 75012 Paris, France
    Bull Cancer 95:F84-8. 2008
  3. ncbi request reprint 'Indolent' Waldenstrom's macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L
    Laurent Garderet
    Department of Hematology, Hopital Saint Antoine, Paris, France
    Eur J Haematol 77:80-2. 2006
  4. pmc Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study
    Laurent Garderet
    INSERM, UMR_S 938, Paris, France
    Haematologica 95:398-405. 2010
  5. ncbi request reprint Mesenchymal stem cell abnormalities in patients with multiple myeloma
    Laurent Garderet
    INSERM, U832, EA1638, Paris, France
    Leuk Lymphoma 48:2032-41. 2007
  6. ncbi request reprint Poor ex vivo induction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma
    Laurent Garderet
    Inserm and EA1638, Faculte de Medecine Saint Antoine, Universite Pierre et Marie Curie Paris 6, Paris, France
    Leuk Lymphoma 47:1340-7. 2006
  7. doi request reprint Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
    Michel Attal
    Department of Hematology, Hopital Purpan, Toulouse, France
    N Engl J Med 366:1782-91. 2012
  8. ncbi request reprint [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
    Corinne Haioun
    Department of Clinical Hematology, H Mondor Hospital, Paris XII University, Assistance Publique Hopitaux de Paris, Creteil, France
    Blood 106:1376-81. 2005
  9. ncbi request reprint Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib
    Laurent Garderet
    Department of Hematology, Saint Antoine Hospital, Paris, France
    Haematologica 92:e9-10. 2007
  10. doi request reprint Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study
    Norbert Claude Gorin
    Department of Hematology and Cell Therapy, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, and University UPMC, Paris, France
    Eur J Haematol 91:315-21. 2013

Collaborators

Detail Information

Publications14

  1. doi request reprint Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomi
    Laurent Garderet
    University Hospital Saint Antoine, Paris, France
    J Clin Oncol 30:2475-82. 2012
    ....
  2. doi request reprint [Treatment of myeloma in the elderly]
    Laurent Garderet
    Hopital Saint Antoine, Service d Hématologie et de Thérapie Cellulaire, 184, rue du Faubourg Saint Antoine, 75012 Paris, France
    Bull Cancer 95:F84-8. 2008
    ..The addition of thalidomide to alkeran plus prednisone has increased overall survival of two years. For the first time, major therapeutic improvements are emerging giving rise to better prognosis...
  3. ncbi request reprint 'Indolent' Waldenstrom's macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L
    Laurent Garderet
    Department of Hematology, Hopital Saint Antoine, Paris, France
    Eur J Haematol 77:80-2. 2006
    ..Very rarely, it is due to a central nervous system localization, the so-called Bing Neel Syndrome. We report a patient with an 'indolent' systemic disease and surprisingly a concomitant major CNS involvement...
  4. pmc Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study
    Laurent Garderet
    INSERM, UMR_S 938, Paris, France
    Haematologica 95:398-405. 2010
    ..In particular, data are lacking on the terminal phase of differentiation of erythroid cells (enucleation) in myelodysplastic syndromes...
  5. ncbi request reprint Mesenchymal stem cell abnormalities in patients with multiple myeloma
    Laurent Garderet
    INSERM, U832, EA1638, Paris, France
    Leuk Lymphoma 48:2032-41. 2007
    ..These data suggest that defective osteoblast function in patients with advanced MM may be related not only to factors released by tumor myeloma cells but also to MSC abnormalities...
  6. ncbi request reprint Poor ex vivo induction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma
    Laurent Garderet
    Inserm and EA1638, Faculte de Medecine Saint Antoine, Universite Pierre et Marie Curie Paris 6, Paris, France
    Leuk Lymphoma 47:1340-7. 2006
    ..In conclusion, the T-cell response to pulsed DCs was very weak or absent. There are clinical and technical reasons that could explain, in part, this lack of response...
  7. doi request reprint Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
    Michel Attal
    Department of Hematology, Hopital Purpan, Toulouse, France
    N Engl J Med 366:1782-91. 2012
    ..Residual disease is almost always present after transplantation and is responsible for relapse. This phase 3, placebo-controlled trial investigated the efficacy of lenalidomide maintenance therapy after transplantation...
  8. ncbi request reprint [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
    Corinne Haioun
    Department of Clinical Hematology, H Mondor Hospital, Paris XII University, Assistance Publique Hopitaux de Paris, Creteil, France
    Blood 106:1376-81. 2005
    ..Predictive value of "early PET" was observed in both the lower-risk and higher-risk groups, indicating prognostic independence from the IPI. Therefore, FDG-PET should be an early guide to first-line strategies in aggressive lymphoma...
  9. ncbi request reprint Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib
    Laurent Garderet
    Department of Hematology, Saint Antoine Hospital, Paris, France
    Haematologica 92:e9-10. 2007
    ..The mother was in complete molecular remission, relapsed during pregnancy and reverted to remission in both cases after delivery...
  10. doi request reprint Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study
    Norbert Claude Gorin
    Department of Hematology and Cell Therapy, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, and University UPMC, Paris, France
    Eur J Haematol 91:315-21. 2013
    ..The surviving patient is still alive after relapse and a second allogeneic stem cell transplantation. This study shows that in relapse/refractory ALL, alemtuzumab with G-CSF can produce good responses of short duration...
  11. doi request reprint Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome
    Alyette Duquesne
    AP HP, Hopital Tenon, Department of Nephrology, Paris, F 75020 France
    Hum Pathol 44:927-33. 2013
    ..After 18 months follow-up, she is in complete hematological, ophthalmological, and renal remission...
  12. ncbi request reprint Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)
    Laurent Garderet
    Centre International de Greffes, AP HP, Universite Paris VI, Paris, France
    Blood 105:405-9. 2005
    ..We conclude that M7 AML patients in CR1 (except children with Down syndrome, who already have better outcomes) can benefit from transplantation...
  13. doi request reprint Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression
    Michelina Nascimbeni
    Institut Cochin, Universite Paris Descartes, Centre National de la Recherche Scientifique CNRS, Unité Mixte de Recherche UMR 8104, Paris, France
    Blood 113:6112-9. 2009
    ..Therefore, pDCs accumulated in spleens from HIV+ patients with high proviral loads, but they did not seem to be the main IFN-alpha producers...
  14. ncbi request reprint A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation
    Kimmo Talvensaari
    Laboratoire d Immunologie et d Histocompatibilité, INSERM U 396, Institut Universitaire d Hématologie Service d Hématologie Greffe de Moelle, Hopital Saint Louis, AP HP, Paris, France
    Blood 99:1458-64. 2002
    ..These data indicate an efficient thymic regeneration pathway from CB lymphoid progenitors despite the low number of cells infused compared to bone marrow, arguing for a complete clinical immune recovery after CB transplantation...